Historical aspects of chirality of drugs
DOI:
https://doi.org/10.24959/sphhcj.16.32Keywords:
drugs, chirality, historical aspects, enantiomers, optical rotationAbstract
Currently only about 15% of all pharmaceutical products synthesized are presented by pure enantiomers.Many medicines exist as a mixture of two, and often a larger number of spatial isomers with a different biological activity. Optical isomers have different biological, pharmacological and technological properties. The optical activity, odor, toxicity, pharmacodynamic, pharmacokinetic and technological properties depend on chirality of the same substance. This led to the study of important aspects of the theory of chirality when creating medicines. The article considers historical aspects of chirality of drugs. Based on the library analysis the mandatory consideration of the chemical nature of chirality of drugs in production of pharmaceuticals, as well as the necessity of the preclinical and clinical trials of drugs have been substantiated. It has been found that creation of pure chiral drugs is a promising research direction. Its introduction into clinical practice allows, firstly, to use lower
doses of drugs without the loss of efficiency, and secondly, to improve the safety and reduce the risk of adverse reactions during therapy.
References
Черних В. П. Органічна хімія / В. П. Черних. – Режим доступу: http://kingmed.info/knigi/Himiya/book_292/Organichna_himiya-Chernih_VP-2004-djvu.
Биологическая активность энантиомеров: хиральный переход. – Режим доступу: http://studopedia.ru/4_8292_razrabotkalekarstv-na-baze-soedineniy-liderov.html.
Марино П. Интенсивная терапия / пер. с англ. – М.: ГЭОТАР-Медиа, 2010. – 768 с.
Борисенко Т. А. Фармацевтична розробка поліелектролітних інфузійних розчинів з глюкозою та малат-іонами: автореферат … канд. фарм. н. – К., 2010. – 20 с.
Лекарства хиральные. – Режим доступу: http://chem21.info/info/318809.
Оптическая изомерия: новое слово в кардиологии. – Режим доступу: http:// health-ua.com/article/2462.html.
ESC Guidelines for the Management of Stable Angina Pectoris // Eur. Heart J. – 2006. – Vol. 27. – P. 1341-1381.
Guidelines for the management of arterial hypertension // J. Hypertension. – 2007. – Vol. 25. – P. 1105-1187.
MERIT-HF Study Group. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure // JAMA. – 2000. – Vol. 283. – P. 1295-1302.
Mehvar R. Stereo specific pharmacokinetics and pharmacodynamics of b-adrenergic blockers in humans / R. Mehvar, D. Brocks // J. Pharm. Pharmaceut. Sci. – 2001. – Vol. 4. – P. 185-200.
Aneja P. Comparative clinical study of efficacy and safety of S-metoprolol ER tablet versus a racemate metoprolol ER tablet in patients with chronic stableangina / P. Aneja, A. Srinivas, A. Das Biswas // Intern. J. Clin. Pharm. Therap. – 2007. – Vol. 45. – P. 253-258.
Jayaram S. The SMART Trial: S-metoprolol Assessment in Hypertension Trial / S. Jayaram, U. Kaul, V. Pai et al. // Cardiology Today. – 2005. – Vol. 9. – P. 222-229.
Фармацевтичні та медико-біологічні аспекти ліків [текст]: навч. посiб. для студ., магістрів, асп., викл., наук. співроб. та спеціалістів фармації / І. М. Перцев, О. Х. Пімінов, М. М. Слободянюк [та ін.]; за ред. І. М. Перцева. – 2-ге вид., перероб. та доп. – Вінниця : Нова Книга, 2007. – 725 с.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
